GLP-1s, taste and what’s happening to our diets
Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
Fitness coach who lost 10 kg fat shares her ‘simple, repeatable and realistic’ plan to achieve weight loss goals
Weight loss is an uphill climb. You need patience, consistency, and healthy goals to achieve it. When you…
Noom launches longevity-focused GLP-1 program
Preventive health offering combines ‘microdosed’ GLP-1 meds with biomarker monitoring and behavior change guidance. Digital health platform Noom…
‘I turned to Mounjaro after receiving online hate and now I feel 20 years younger’
Labour MP Carolyn Harris said she didn’t want people to look at her when she entered a room,…
39-stone man loses half his bodyweight with one exercise
He has shed 18 stone in 21 monthsNeil Shaw Assistant Editor (Money and Lifestyle) 08:06, 14 Dec 2025…
Fitness trainer explains ‘how to lose 4 kg before 2025 ends’ without a crash diet or extreme workouts
Published on: Dec 13, 2025 01:16 pm IST Think it’s too late to lose weight this year? Fitness…
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments
How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…
The ‘life-changing’ drugs being used by thousands of people in Wales every day
Many people have heaped praise on so-called skinny jabs, but questions over how they are being prescribed and…
Ancient walking trend could ‘aid heart health’ with 30-minute workouts
As the New Year approaches, many Brits will be contemplating ways to enhance their health habits. In response…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…
Docs call for GLP-1 warning label due to ‘very dangerous’ risk
There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in…